Access cutting-edge epilepsy treatment through this clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Palo Alto location
Preparing your pre-screening questions…
Access epilepsy specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related epilepsy treatment provided free
Check if you qualify for this epilepsy clinical trial in Palo Alto, CA
No-Cost Study Care
Local to Palo Alto
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The purpose of this research is to address the challenges of correctly monitoring, managing, and diagnosing epilepsy in participants whose seizures are not well captured by standard electroencephalography (EEG) tests and who cannot use or are not able to use more standard monitoring techniques. This research is being done to understand how the Minder System helps physicians make decisions about participant's epilepsy treatment after an actionable event. The Minder System was granted De Novo classification by the U.S. Food and Drug Administration (FDA) and is not investigational. Participants that have completed the DETECT study and received the Minder System previously will consent to join this long-term follow-up observational study. The study will collect information about general wellbeing, use of healthcare services, and experience using the Minder data over time to support long-term epilepsy care. All participants will continue to be followed by their treating physician and undergo assessments and visits every six (6) months until two (2) years after receiving the Minder device.
Sponsor: Epiminder America, Inc.
Yes, this clinical trial (NCT07110454) has an active research site in Palo Alto, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for epilepsy treatment options in Palo Alto, CA, this clinical trial (NCT07110454) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Palo Alto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced epilepsy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all epilepsy clinical trials near you to find additional studies recruiting in your area.
See all epilepsy clinical trials recruiting in Palo Alto — not just this study.
Browse Epilepsy Trials in Palo Alto →